News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Agenus Thanks ESMO and Ben Schlechter for Sharing the New Data of BOT/BAL in Refractory MSS CRC
dana-farber.org
Jul 10, 2025, 14:35

Agenus Thanks ESMO and Ben Schlechter for Sharing the New Data of BOT/BAL in Refractory MSS CRC

Agenus shared on LinkedIn:

“Thank you to ESMO – European Society for Medical Oncology-GI and Dr. Ben Schlechter of Dana-Farber Cancer Institute for sharing the new data of BOT/BAL in refractory MSS colorectal cancer.”

More posts about ESMOGI25.

Agenus Ben Schlechter cancer colorectal cancer CRC ESMO-GI OncoDaily Oncology
Special Coverage
Blog
Jul 10, 2025, 14:35
Agenus Thanks ESMO and Ben Schlechter for Sharing the New Data of BOT/BAL in Refractory MSS CRC
Science
Jul 10, 2025, 14:26
Myeloma Paper of the Day, July 10th, Suggested by Robert Orlowski
Blog
Jul 10, 2025, 14:16
Voice of the Families, Post 36 Ninsimma and Her Mother - CANCaRe Africa
Career
Jul 10, 2025, 14:15
Leadership Transition: Brad Cairns to Lead Huntsman Cancer Institute After Mary Beckerle’s Tenure
Blog
Jul 10, 2025, 14:01
Eugene Woods: Advocate Health Expands Rural Commitment with $100M Investment in Yadkin Valley
Blog
Jul 10, 2025, 13:53
Ulrika Årehed Kågström Calls on the Cancer Community to Help Make the Second Half of 2025 Count - UICC
Science
Jul 10, 2025, 13:47
Kevin Harrington: STING Agonist Therapy with Ulevostinag - From ESMO 2018 to Print
Science
Jul 10, 2025, 13:13
Ilyas Sahin: Good News in Cancer Screening
Blog
Jul 10, 2025, 13:01
Olivier Elemento: Beyond the Abstract - The Next Evolution for AI Co-Scientists
Blog
Jul 10, 2025, 11:33
David Planchard: Departure of a Giant of Genito-urinary Oncology from Gustave Roussy
Blog
Jul 10, 2025, 11:26
Fumiko Ladd Chino: My Financial Toxicity Mitigation Thoughts
Blog
Jul 10, 2025, 11:12
Rahul Banerjee: Largest RW Experience with Teclistamab